evaluate the pharmaceuticals company saxenda on amgen and glp-1 Beyond GLP-1: next wave of weight-loss medication innovation GLP-1 Weight Loss Drug Market

Fat Loss & Metabolic Support: Enhances lipolysis (fat breakdown) while preserving muscle, especially around the midsection

doi: 10.3389/fimmu.2026.1730351 Received 22 October 2025 Revised 28 January 2026 Accepted 24 February 2026 Published 25 March 2026 Volume 17 - 2026 Edited by Chafia Touil-Boukoffa, University of Science and Technology Houari Boumediene, Algeria Reviewed by Nar Singh Chauhan, Maharshi Dayanand University, India Fatma Naz Cemre Kalayci, DanaFarber Cancer Institute, United States Updates Copyright 2026 Zhan, Wang, Zhan, Yang, Liang, Yu and Wang

The compliance gap is widening

It means you should be intentional

In this study, coimmunoprecipitation-mass spectrometry (co-IP-MS) identified FBXO22 as a direct intracellular interactor of BPC157